GlaxoSmithKline (GSK) is currently conducting a Phase 2/3 clinical study titled ‘A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung ...

GlaxoSmithKline (GSK) and Ideaya Biosciences are conducting a study titled A Phase 1/2 First-Time-in-Human, Open-label, Multicenter, Dose Escalation and Expansion Study of the Oral DNA Helicase ...

CAFC Finds No Written Description Support for Identifying Type of Display Unit – On Friday, August 8, the U.S. Court of Appeals for the Federal Circuit issued a precedential ruling in Mondis ...

Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the mRNA vaccine technology that was at the forefront of the world's fight ...

GSK said the upfront settlement amount will be recorded as other operating income in its financial results as an adjusting item in the income statement in the third quarter of 2025. The 2025 and ...

A phase 2b trial of HMNC Brain Health’s depression drug candidate has missed its primary endpoint. But while the ex-Sanofi molecule failed to move the needle in the pre-specified population ...

We have the answer for The "G" of the pharmaceutical company GSK crossword clue that will help you solve the crossword puzzle you're working on!

Last month, Hengrui Pharmaceuticals announced a blockbuster licensing deal with GSK worth up to USD 12.5 billion, with an upfront payment of USD 500 million. The deal grants GSK the overseas rights to ...

Although obinutuzumab has not yet received FDA approval in lupus nephritis, findings from a recent survey conducted by Spherix Global Insights indicated increasing use and comfort with this ...

The prefilled syringe presentation offers a convenient administration option to healthcare professionals.

British pharmaceutical giant GSK Plc (NYSE:GSK) shares rose on Wednesday after reporting second-quarter results that surpassed analyst expectations and led the company to raise its full-year 2025 ...

GSK is sticking to its projection to generate more than 40 billion pounds of sales in 2031, regardless of whether it regains U.S. approval of Blenrep.